Author: News Room
SAN DIEGO, Sept. 04, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Sage Therapeutics, Inc. (NASDAQ: SAGE) securities between April 12, 2021 and July 23, 2024. Sage is a biopharmaceutical company that develops and commercializes brain health medicines. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Sage Therapeutics, Inc. (SAGE) Misled Investors Regarding the Efficacy of its New Drugs According to the complaint,…
SAN DIEGO, Sept. 04, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Verve Therapeutics, Inc. (NASDAQ: VERV) securities between August 9, 2022 and April 1, 2024. Verve is a “clinical-stage genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines.” For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Verve Therapeutics,…
SAN DIEGO, Sept. 04, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Starbucks Corporation (NASDAQ: SBUX) securities between November 2, 2023 and April 30, 2024. Starbucks is an American multinational chain of coffeehouses and roastery reserves. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Starbucks Corporation (SBUX) Misled Investors Regarding its Business Prospects According to the complaint, during the class period, defendants created…
CHICAGO, Sept. 04, 2024 (GLOBE NEWSWIRE) — nuEra Cannabis, a leading cannabis company in Illinois, is proud to announce a special one-day fundraiser in honor of Hispanic Heritage Month. On September 15, 2024, nuEra Cannabis will be hosting this event to support The Latino Medical Student Association, emphasizing the company’s commitment to community engagement and cultural celebration. The fundraiser will take place across all nuEra dispensary locations in Illinois. 5% of sales of nuEra House of Brand products (such as nuEra, Midweek Friday, Interstate 420, among other brands) will be donated directly to The Latino Medical Student Association, an organization…
SAN DIEGO, Sept. 04, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Methode Electronics, Inc. (NYSE: MEI) common stock between June 23, 2022 and March 6, 2024. Methode designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (“OEMs”). For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Methode Electronics, Inc. (MEI) Misled Investors Regarding its Business Prospects According to the complaint, defendants’ failure…
SPOKANE, Wash., Sept. 04, 2024 (GLOBE NEWSWIRE) — nomnom, a wholly owned subsidiary of Par Pacific Holdings, Inc., and official sponsor of The Eastern Washington University Eagles (EWU), is proud to offer nomnom rewards members a chance to win the Snack Attack prize package. All nomnom rewards members can enter to win VIP tickets to watch the Eagles play on November 16th, 2024. The nomnom “Snack Attack” package includes four passes to the game and access to the EWU hospitality suite, which features complimentary refreshments and an eagle-eye view of the game! “We’re thrilled to provide Eagles fans with an…
SAN DIEGO, Sept. 04, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Outset Medical, Inc. (NASDAQ: OM) securities between August 1, 2022 and August 7, 2024. Outset Medical is a medical technology company. Its primary products are the Tablo series devices used in dialysis care, including the Tablo Hemodialysis System and the TabloCart. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Outset Medical,…
San Diego, CA, Sept. 04, 2024 (GLOBE NEWSWIRE) — Cloudbeds, the premier hospitality management platform, is set to usher in the era of ‘decision intelligence’ for the hospitality industry at its upcoming Passport User Conference on October 23, with the unveiling of Cloudbeds Intelligence. Cloudbeds Intelligence, a new AI and machine learning layer built into the platform, is designed to supercharge all functionalities of the hospitality management system and break down departmental silos, delivering unmatched decision-making intelligence for revenue managers, marketers, GMs, operations staff, and more. The innovative platform layer implements causal AI using rich datasets within the Cloudbeds platform…
SAN DIEGO, Sept. 04, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Endava PLC (NYSE: DAVA) securities between May 23, 2023 and February 28, 2024. Endava provides technology services for clients in consumer products, healthcare, mobility, and retail verticals in North America. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Endava PLC (DAVA) Misled Investors Regarding its Business Prospects According to the complaint,…
LAS VEGAS, NV, Sept. 04, 2024 (GLOBE NEWSWIRE) — Golden Matrix Group (NASDAQ: GMGI) today announced the launch of Version 2.0 of its AI-powered casino game recommender, developed by its subsidiary, Meridianbet. This update specifically targets the iGaming segment, enhancing personalization and tracking capabilities to improve user engagement, retention, and revenue performance. Precision Personalization for Improved User Targeting The V2 recommender now processes an expanded dataset, including player behaviors and demographics, delivering more precise game recommendations that resonate with individual preferences, offering advanced AI-driven insights: Proven Impact on Key Revenue Metrics Initial data shows significant increases in user interaction and…